The Geriatric Nutritional Risk Index Predicts Tolerability of Lenvatinib in Patients With Hepatocellular CarcinomaAkiyoshi Kinoshita, Masayuki Saruta, Noriko Hagiwara et al.|In Vivo|2022Cited by 14
Endoscopic submucosal dissection in a patient with esophageal adenoid cystic carcinomaKenichi Yoshikawa, Masayuki Saruta, Akiyoshi Kinoshita et al.|World Journal of Gastroenterology|2017Cited by 13
Mesalazine formulation intolerance due to suspected excipient allergy in the treatment of ulcerative colitis: a case reportYoshinori Arai, Masayuki Saruta, Maiko Ogawa et al.|Clinical Journal of Gastroenterology|2020Cited by 8
Liver injury after aluminum potassium sulfate and tannic acid treatment of hemorrhoidsKenichi Yoshikawa, Masayuki Saruta, Reimi Kawashima et al.|World Journal of Gastroenterology|2017Cited by 8
Poor tolerability of lenvatinib in elderly patients ≥80 years old with hepatocellular carcinoma: A multicenter observational studyAkiyoshi Kinoshita, Masayuki Saruta, Noriko Hagiwara et al.|Journal of Oncology Pharmacy Practice|2022Cited by 3